Global (United States, European Union and China) Biologic Drugs Market Research Report 2019-2025

Publisher Name :
Date: 24-May-2019
No. of pages: 110
Inquire Before Buying

In 2019, the market size of Biologic Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologic Drugs.

This report studies the global market size of Biologic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Biologic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Roche

- Abbott Laboratories

- Johnson & Johnson

- Merck & Co.

- Pfizer

- Amgen

- Sanofi

- Novartis

- Eli Lilly

- Amgen

Market Segment by Product Type

- Humira

- Remicade

- Rituxan

- Enbrel

- Lantus

- Avastin

- Herceptin

- Others

Market Segment by Application

- Diabetes

- Inflammation

- Auto-Immune Diseases

- Blood Diseases

- Cardiovascular Diseases

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Biologic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Biologic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biologic Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Biologic Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biologic Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Humira
1.3.3 Remicade
1.3.4 Rituxan
1.3.5 Enbrel
1.3.6 Lantus
1.3.7 Avastin
1.3.8 Herceptin
1.3.9 Others
1.4 Market Segment by Application
1.4.1 Global Biologic Drugs Market Share by Application (2019-2025)
1.4.2 Diabetes
1.4.3 Inflammation
1.4.4 Auto-Immune Diseases
1.4.5 Blood Diseases
1.4.6 Cardiovascular Diseases
1.4.7 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Drugs Market Size
2.1.1 Global Biologic Drugs Revenue 2014-2025
2.1.2 Global Biologic Drugs Sales 2014-2025
2.2 Biologic Drugs Growth Rate by Regions
2.2.1 Global Biologic Drugs Sales by Regions 2014-2019
2.2.2 Global Biologic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biologic Drugs Sales by Manufacturers
3.1.1 Biologic Drugs Sales by Manufacturers 2014-2019
3.1.2 Biologic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Biologic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Biologic Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Biologic Drugs Price by Manufacturers
3.4 Key Manufacturers Biologic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biologic Drugs Market
3.6 Key Manufacturers Biologic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Humira Sales and Revenue (2014-2019)
4.1.2 Remicade Sales and Revenue (2014-2019)
4.1.3 Rituxan Sales and Revenue (2014-2019)
4.1.4 Enbrel Sales and Revenue (2014-2019)
4.1.5 Lantus Sales and Revenue (2014-2019)
4.1.6 Avastin Sales and Revenue (2014-2019)
4.1.7 Herceptin Sales and Revenue (2014-2019)
4.1.8 Others Sales and Revenue (2014-2019)
4.2 Global Biologic Drugs Sales Market Share by Type
4.3 Global Biologic Drugs Revenue Market Share by Type
4.4 Biologic Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biologic Drugs Sales by Application
6 United States
6.1 United States Biologic Drugs Breakdown Data by Company
6.2 United States Biologic Drugs Breakdown Data by Type
6.3 United States Biologic Drugs Breakdown Data by Application
7 European Union
7.1 European Union Biologic Drugs Breakdown Data by Company
7.2 European Union Biologic Drugs Breakdown Data by Type
7.3 European Union Biologic Drugs Breakdown Data by Application
8 China
8.1 China Biologic Drugs Breakdown Data by Company
8.2 China Biologic Drugs Breakdown Data by Type
8.3 China Biologic Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biologic Drugs Breakdown Data by Company
9.2 Rest of World Biologic Drugs Breakdown Data by Type
9.3 Rest of World Biologic Drugs Breakdown Data by Application
9.4 Rest of World Biologic Drugs Breakdown Data by Countries
9.4.1 Rest of World Biologic Drugs Sales by Countries
9.4.2 Rest of World Biologic Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biologic Drugs
10.1.4 Biologic Drugs Product Introduction
10.1.5 Roche Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biologic Drugs
10.2.4 Biologic Drugs Product Introduction
10.2.5 Abbott Laboratories Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biologic Drugs
10.3.4 Biologic Drugs Product Introduction
10.3.5 Johnson & Johnson Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biologic Drugs
10.4.4 Biologic Drugs Product Introduction
10.4.5 Merck & Co. Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biologic Drugs
10.5.4 Biologic Drugs Product Introduction
10.5.5 Pfizer Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biologic Drugs
10.6.4 Biologic Drugs Product Introduction
10.6.5 Amgen Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biologic Drugs
10.7.4 Biologic Drugs Product Introduction
10.7.5 Sanofi Recent Development
10.8 Novartis
10.8.1 Novartis Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biologic Drugs
10.8.4 Biologic Drugs Product Introduction
10.8.5 Novartis Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biologic Drugs
10.9.4 Biologic Drugs Product Introduction
10.9.5 Eli Lilly Recent Development
10.10 Amgen
10.10.1 Amgen Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Biologic Drugs
10.10.4 Biologic Drugs Product Introduction
10.10.5 Amgen Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biologic Drugs Sales Channels
11.2.2 Biologic Drugs Distributors
11.3 Biologic Drugs Customers
12 Market Forecast
12.1 Global Biologic Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Biologic Drugs Sales Forecast by Type
12.3 Global Biologic Drugs Sales Forecast by Application
12.4 Biologic Drugs Forecast by Regions
12.4.1 Global Biologic Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Biologic Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Biologic Drugs Product Picture
Table Biologic Drugs Key Market Segments
Table Major Manufacturers Biologic Drugs Covered in This Report
Table Global Biologic Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Biologic Drugs Sales Market Shar by Type 2014-2025
Figure Humira Figures
Table Major Manufacturers of Humira
Figure Remicade Figures
Table Major Manufacturers of Remicade
Figure Rituxan Figures
Table Major Manufacturers of Rituxan
Figure Enbrel Figures
Table Major Manufacturers of Enbrel
Figure Lantus Figures
Table Major Manufacturers of Lantus
Figure Avastin Figures
Table Major Manufacturers of Avastin
Figure Herceptin Figures
Table Major Manufacturers of Herceptin
Figure Others Figures
Table Major Manufacturers of Others
Table Global Biologic Drugs Market Share by Application 2019-2025 (K Units)
Figure Diabetes Use Case
Figure Inflammation Use Case
Figure Auto-Immune Diseases Use Case
Figure Blood Diseases Use Case
Figure Cardiovascular Diseases Use Case
Figure Others Use Case
Figure Biologic Drugs Report Years Considered
Figure Global Biologic Drugs Market Size 2014-2025 (Million US$)
Figure Global Biologic Drugs Sales 2014-2019 (K Units)
Table Global Biologic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biologic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Biologic Drugs Sales Market Share by Regions 2014-2019
Figure Global Biologic Drugs Sales Market Share by Regions 2014-2019
Figure Global Biologic Drugs Sales Market Share by Regions in 2019
Table Global Biologic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Biologic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Biologic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Biologic Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Biologic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Biologic Drugs Sales Share by Manufacturers in 2019
Table Biologic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Biologic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Biologic Drugs Value Share by Manufacturers in 2019
Table Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biologic Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Biologic Drugs Plants/Factories Distribution
Table Key Manufacturers Biologic Drugs Area Served
Table Date of Key Manufacturers Enter into Biologic Drugs Market
Table Key Manufacturers Biologic Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Humira Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Remicade Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Rituxan Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Enbrel Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Lantus Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Avastin Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Herceptin Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Others Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Biologic Drugs Sales by Type (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by Type (2014-2019)
Figure Global Biologic Drugs Sales Market Share by Type (2014-2019)
Figure Global Biologic Drugs Sales Market Share by Type in 2018
Table Global Biologic Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Biologic Drugs Revenue Share by Type (2014-2019)
Figure Global Biologic Drugs Revenue Market Share by Type (2014-2019)
Figure Global Biologic Drugs Revenue Market Share by Type in 2018
Table Biologic Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Biologic Drugs Sales by Application (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by Application (2014-2019)
Figure Global Sales Biologic Drugs Market Share by Application (2014-2019)
Figure Global Sales Biologic Drugs Market Share by Application (2014-2019)
Figure United States Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Biologic Drugs Sales by Company (2014-2019) (K Units)
Table United States Biologic Drugs Sales Market Share by Company (2014-2019)
Figure United States Biologic Drugs Sales Market Share by Company in 2019
Table United States Biologic Drugs Sales by Type (2014-2019) (K Units)
Table United States Biologic Drugs Sales Market Share by Type (2014-2019)
Figure United States Biologic Drugs Market Share by Type in 2019
Table United States Biologic Drugs Sales by Application (2014-2019) (K Units)
Table United States Biologic Drugs Sales Market Share by Application (2014-2019)
Figure United States Biologic Drugs Market Share by Application in 2019
Figure European Union Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Biologic Drugs Sales by Company (2014-2019) (K Units)
Table European Union Biologic Drugs Sales Market Share by Company (2014-2019)
Figure European Union Biologic Drugs Sales Market Share by Company in 2019
Table European Union Biologic Drugs Sales by Type (2014-2019) (K Units)
Table European Union Biologic Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Biologic Drugs Market Share by Type
Table European Union Biologic Drugs Sales by Application (2014-2019) (K Units)
Table European Union Biologic Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Biologic Drugs Market Share by Application
Figure China Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Biologic Drugs Sales by Company (2014-2019) (K Units)
Table China Biologic Drugs Sales Market Share by Company (2014-2019)
Figure China Biologic Drugs Sales Market Share by Company in 2019
Table China Biologic Drugs Sales by Type (2014-2019) (K Units)
Table China Biologic Drugs Sales Market Share by Type (2014-2019)
Figure China Biologic Drugs Market Share by Type in 2019
Table China Biologic Drugs Sales by Application (2014-2019) (K Units)
Table China Biologic Drugs Sales Market Share by Application (2014-2019)
Figure China Biologic Drugs Market Share by Application in 2019
Figure Rest of World Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Biologic Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Biologic Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Biologic Drugs Sales Market Share by Company in 2019
Table Rest of World Biologic Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Biologic Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Biologic Drugs Market Share by Type in 2019
Table Rest of World Biologic Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Biologic Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Biologic Drugs Market Share by Application in 2019
Table Rest of World Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Biologic Drugs Sales Market Share by Countries in 2019
Table Rest of World Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Biologic Drugs Revenue Market Share by Countries in 2019
Figure Japan Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biologic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biologic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Biologic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Biologic Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Roche Company Details
Table Roche Description and Business Overview
Table Roche Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Biologic Drugs Sales Growth Rate (2014-2019)
Table Roche Biologic Drugs Sales Market Share in Global Market
Table Roche Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Biologic Drugs Sales Growth Rate (2014-2019)
Table Abbott Laboratories Biologic Drugs Sales Market Share in Global Market
Table Abbott Laboratories Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Biologic Drugs Sales Growth Rate (2014-2019)
Table Johnson & Johnson Biologic Drugs Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Description and Business Overview
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Biologic Drugs Sales Growth Rate (2014-2019)
Table Merck & Co. Biologic Drugs Sales Market Share in Global Market
Table Merck & Co. Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Biologic Drugs Sales Growth Rate (2014-2019)
Table Pfizer Biologic Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Description and Business Overview
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Biologic Drugs Sales Growth Rate (2014-2019)
Table Amgen Biologic Drugs Sales Market Share in Global Market
Table Amgen Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Biologic Drugs Sales Growth Rate (2014-2019)
Table Sanofi Biologic Drugs Sales Market Share in Global Market
Table Sanofi Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Biologic Drugs Sales Growth Rate (2014-2019)
Table Novartis Biologic Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Biologic Drugs Sales Growth Rate (2014-2019)
Table Eli Lilly Biologic Drugs Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table Amgen Company Details
Table Amgen Description and Business Overview
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Biologic Drugs Sales Growth Rate (2014-2019)
Table Amgen Biologic Drugs Sales Market Share in Global Market
Table Amgen Recent Development
Figure Biologic Drugs Value Chain
Table Biologic Drugs Distributors List
Table Biologic Drugs Customers List
Table Global Biologic Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Biologic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Biologic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Biologic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Biologic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Biologic Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Biologic Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Biologic Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure China Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure India Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Biologic Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Biologic Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs